N. E. Gefen
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- Extracellular vesicles in disease
- RNA Research and Splicing
Papers in ⓘ
-
- Molecular Biology Techniques and Applications 2
- Circular RNAs in diseases 2
- RNA Interference and Gene Delivery 2
- Epigenetics and DNA Methylation 1
- Bacillus and Francisella bacterial research 1
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 2
- Cancer Genomics and Diagnostics 1
- Co-authors
- Shai Izraeli (3 shared papers)Vera Binder (2 shared papers)Arndt Borkhardt (2 shared papers)Nitzan Rosenfeld (1 shared paper)Karin Ashkenazi (1 shared paper)Gideon Rechavi (1 shared paper)Harvey I. Pass (1 shared paper)Shlomit Gilad (1 shared paper)
- Journals
- Leukemia (2 papers)Journal of Clinical Oncology (1 paper)Cancer Biology & Therapy (1 paper)PLoS ONE (1 paper)PubMed (2 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
N. E. Gefen
7 papers receiving 667 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 528
- Molecular Biology 550
- Hematology 30
- Immunology 45
- Oncology 56
Countries citing papers authored by N. E. Gefen
This map shows the geographic impact of N. E. Gefen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. E. Gefen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. E. Gefen more than expected).
Fields of papers citing papers by N. E. Gefen
This network shows the impact of papers produced by N. E. Gefen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. E. Gefen. The network helps show where N. E. Gefen may publish in the future.
Co-authors
The 25 scholars most cited alongside N. E. Gefen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 326 | |
| 2 | 2012 | 151 | |
| 3 | 2009 | 92 | |
| 4 | 2011 | 74 | |
| 5 | Identification of differentially expressed mRNA transcripts in drug-resistant versus parental human melanoma cell lines. | 2006 | 26 |
| 6 | 2010 | 9 | |
| 7 | [Reactivity to and effectiveness of aerogenic vaccination against certain zoonoses]. | 1958 | 2 |
| 8 | EXPERIMENT OF MASS AEROGENIC VACCINATION OF HUMANS AGAINST ANTHRAX | 1968 | 1 |
About N. E. Gefen
N. E. Gefen is a scholar working on Molecular Biology, Cancer Research, Public Health, Environmental and Occupational Health, Infectious Diseases and Organic Chemistry, having authored 8 papers that have together received 681 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (2 papers), Molecular Biology Techniques and Applications (2 papers), Circular RNAs in diseases (2 papers), RNA Interference and Gene Delivery (2 papers), Epigenetics and DNA Methylation (1 paper), Cancer Genomics and Diagnostics (1 paper) and Bacillus and Francisella bacterial research (1 paper). The work is most often cited by research in Cancer Research (528 citations), Molecular Biology (550 citations), Hematology (30 citations), Immunology (45 citations) and Oncology (56 citations). N. E. Gefen has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Shai Izraeli, Vera Binder, Arndt Borkhardt, Nitzan Rosenfeld, Karin Ashkenazi, Gideon Rechavi, Harvey I. Pass, Shlomit Gilad, Yael Spector and Ayelet Chajut. Their work appears in journals such as Leukemia, Journal of Clinical Oncology, Cancer Biology & Therapy, PLoS ONE and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.